Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
Does Fridays an online company have a good consumer rating for providing tirzepitide
Executive Summary
Fridays (also called Friday Plans or Fridays Health in the materials) has conflicting consumer ratings: multiple Trustpilot-derived summaries report strong, high-volume positive scores and explicit claims that Fridays offers tirzepatide as part of its weight‑loss program, while at least one consumer‑review snapshot on ConsumerAffairs reports a single 1‑star complaint alleging non‑delivery and a charge with no refund [1] [2] [3] [4]. The available analyses show large differences in review counts and tone that point to either disparate data snapshots, multiple similarly named services, or selective sampling rather than a single settled consumer rating for tirzepatide from this company [1] [4] [3].
1. The loudest claims: high praise and very negative outlier — what reviewers say about service and tirzepatide
The strongest recurring claim across the analyses is that Fridays provides tirzepatide through its telehealth weight‑loss program and that many users report positive outcomes and smooth service; summaries cite thousands of Trustpilot reviews and average ratings in the 4.5–4.7 range, with specific praise for fast service, caring clinicians, transparent pricing and convenient delivery [1] [2] [3]. At the same time a ConsumerAffairs listing captures a single, sharply negative 1‑star report alleging a $359 monthly charge, non‑receipt of medication and an inability to obtain a refund; that entry is presented as representative in that source’s snapshot, producing a contrasting narrative of a possible scam [4]. These competing claims create an unclear overall picture without reconciling sample size or timing.
2. Why the reviews diverge so sharply — data volume, platform differences and name confusion
Trustpilot‑based summaries describe thousands of reviews and multi‑star averages (4.5–4.7), which implies broad user feedback and a consistently positive pattern in those snapshots [1] [3]. In contrast, the ConsumerAffairs entry is a single negative review reflected as a 1.0 overall score, which can drastically skew perceptions when presented alone [4]. Another analysis notes that some sources do not even mention Fridays in the tirzepatide context or focus on other clinics, suggesting either different companies with similar names or mismatched coverage windows [5]. The divergence likely stems from platform sample sizes, selective aggregation, and the presence of multiple brand variants like “Fridays,” “Fridays Health,” and “Friday Plans” across the dataset [1] [5] [3].
3. Does Fridays actually offer tirzepatide? The evidence in the samples
Several analyses explicitly state that Fridays offers compounded tirzepatide as part of its weight‑loss program and tie that offering to high review scores and reported weight‑loss results, including concrete user anecdotes and ratings on review platforms [6] [1] [2]. Conversely, other analyses for similarly named services either omit tirzepatide entirely or list different clinics as providers, which raises the question of whether some pages are about different companies or services where tirzepatide isn’t mentioned at all [3] [5]. The mixed documentation means the claim that “Fridays provides tirzepatide” is supported in multiple summaries but not uniformly confirmed across all examined pages, so the offering appears asserted but inconsistently recorded.
4. What customers praise and what they complain about — consistent patterns across sources
Across positive summaries, customers emphasize effective weight loss, timely delivery, helpful virtual consultations and acceptable pricing, with some reviewers reporting marked weight changes and good clinical support [1] [2]. Negative feedback—most starkly visible in the ConsumerAffairs single review—focuses on billing disputes, non‑delivery of medication and poor refund handling, which, if accurate, represent material risks for prospective patients [4]. Additional analyses note occasional communication and prescription‑management problems even among mostly positive reviews, signaling that operational hiccups (shipping, refills, customer service) are the primary recurring complaints rather than wholesale ineffectiveness of the medication in the positive narratives [1] [2].
5. The practical takeaway for consumers researching tirzepatide from Fridays
Given the conflicting review snapshots, consumers should not treat any single platform’s rating as definitive; instead verify which specific entity (Fridays/Friday Plans/Fridays Health) is under review, check review volume and dates, confirm pharmacy and refund policies, and ask for explicit documentation about tirzepatide compounding and delivery before paying [1] [3] [4]. The dataset shows both substantial positive feedback on Trustpilot‑style summaries and at least one severe consumer complaint; that combination indicates a generally positive pattern in some channels but real customer‑service risk in others, so corroborating details and direct verification are essential [2] [4].